Chris Parker, MD

Articles by Chris Parker, MD

Dr. Parker on the Optimal Timing of Salvage Therapy in Prostate Cancer

ByChris Parker, MD

April 27th 2020

Chris Parker, MD, discusses the optimal timing of salvage radiotherapy for men with prostate cancer.

Dr. Parker on the Rationale for the RADICALS-RT Trial in Prostate Cancer

ByChris Parker, MD

April 20th 2020

Chris Parker, MD, discusses the rationale for the phase III RADICALS-RT trial in prostate cancer.

Dr. Parker on the Results of the RADICALS-RT Trial in Prostate Cancer

ByChris Parker, MD

March 27th 2020

Chris Parker, MD, consultant clinical oncologist, The Royal Marsden NHS Foundation Trust, discusses the results of the phase III RADICALS-RT trial in prostate cancer.

Dr. Parker on Radiotherapy in Metastatic Prostate Cancer

ByChris Parker, MD

January 3rd 2019

Chris Parker, MD, consultant clinical oncologist, The Royal Marsden NHS Foundation Trust, discusses the role of radiotherapy in patients with metastatic prostate cancer.

Dr. Parker on the Rationale for Radiotherapy in Metastatic Prostate Cancer

ByChris Parker, MD

November 14th 2018

Chris Parker, MD, consultant clinical oncologist, The Royal Marsden NHS Foundation Trust, discusses the rationale for radiotherapy in the treatment of newly-diagnosed metastatic prostate cancer.

Dr. Parker on the Role of Radiotherapy in Newly Diagnosed Prostate Cancer

ByChris Parker, MD

October 22nd 2018

Chris Parker, MD, consultant clinical oncologist, The Royal Marsden NHS Foundation Trust, discusses the role of radiotherapy in newly diagnosed prostate cancer.